WC Bioscience Accelerator Participants

Nervosave Therapeutics

Technologies

Therapeutic

Indication

Autoimmune & Inflammation

Central Nervous System Disorders

Clinical Research

Clinical Trials

Metabolic Disease

Neurodegenerative Disease

Obesity

Orphan Diseases

Executive Summary

View/Download

Website

nervosavetx.com

Cathy Beaumard

Nervosave is an early-stage biotech company incorporated in Montpellier, France & New York, USA, with a focus on the prevention and cure of myelin-related disorders.

Contact Next Milestone

Newsletter Signup

Name
First Last
Email*
CAPTCHA
Comments
This field is for validation purposes and should be left unchanged.

Corporate Supporters

For more information please contact Program Manager,
Mary Howard at Mary@FirstXFounder.com

Westchester County Biosciences Accelerator is a Program of

FOLLOW US ON

Initiated by